首页> 外文期刊>RSC Advances >Biodegradable polymer-platinum drug conjugates to overcome platinum drug resistance
【24h】

Biodegradable polymer-platinum drug conjugates to overcome platinum drug resistance

机译:可生物降解的聚合物-铂药物共轭物,克服了铂类药物的耐药性

获取原文
获取原文并翻译 | 示例
           

摘要

Drug resistance and severe dose-dependent side effects are the major obstacles to the further use of platinum agents. Two well-acknowledged mechanisms of resistance are the decreased intracellular accumulation and the increased sulfur-binding-detoxification of platinum agents. The polymer-drug conjugate approach can remarkably enhance the uptake of substances by cancer cells, therefore can achieve better anticancer effects with lower dosage, and thus reduce the dose-dependent side effects. Here we synthesized a biodegradable polymer containing pendant 1,2-bidentate carboxyl groups to chelate platinum without introducing sulfur atoms to potentially detoxify the platinum drugs. The polymer-platinum conjugate formed nanomicelles showed significantly increased intracellular accumulation and could partially overcome drug resistance in ovarian cancer cells.
机译:耐药性和严重的剂量依赖性副作用是铂试剂进一步使用的主要障碍。两种公认的抗药性机制是减少细胞内积累和增加铂试剂的硫结合解毒作用。聚合物-药物缀合物方法可以显着提高癌细胞对物质的吸收,因此可以以较低的剂量获得更好的抗癌作用,从而减少剂量依赖性的副作用。在这里,我们合成了一种可生物降解的聚合物,该聚合物包含1,2-双侧链的羧基,可以螯合铂,而不会引入硫原子来潜在地使铂药物解毒。聚合物-铂结合物形成的纳米胶束显示细胞内积累显着增加,并且可以部分克服卵巢癌细胞中的耐药性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号